Skip to content

Effect of non-opioid anesthesia on negative emotions in early postoperative period of thoracoscopic patients: a randomized, double-blind and controlled trial

Effect of non-opioid anesthesia on negative emotions in early postoperative period of thoracoscopic patients: a randomized, double-blind and controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096602
Enrollment
Unknown
Registered
2025-01-26
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Negative emotions in the early postoperative period after thoracoscopy

Interventions

Opioid-free anesthesia group:Anesthesia induces a loading dose of dexmedetomidine 0.5 µg/kg (within 10 minutes), followed by midazolam 0.05 mg/kg, esketamine 0.3~0.5 mg/kg, propofol 1~2 mg/kg, and cis
Opioid anesthesia group:Anesthesia induced midazolam 0.05 mg/kg, sufentanil 0.3~0.5 µg/kg, propofol 1~2 mg/kg and cisatracurium 0.2 mg/kg were induced. Propofol 4~6 mg/(kg · h), sevoflurane (1~2%), re

Sponsors

Affiliated Hospital of Chengdu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Preoperative imaging confirmed pulmonary nodules, and it is planned to perform video-assisted thoracoscopic surgery with general anesthesia by bronchial intubation, including: pulmonary wedge resection, segmental resection, partial pneumonectomy and lobectomy; (2). Age 18-80 years old; ASA I~III; Body Mass Index (BMI) is 18.5 ~ 30kg/m^2; (3) Patients and their families agree to participate in this study and sign the informed consent form; (4) Be able to understand the use and content of research-related scales.

Exclusion criteria

Exclusion criteria: (1) Patients with severe cardiovascular and cerebrovascular diseases or hepatic and renal insufficiency; (2) Patients who used immunosuppressants during perioperative period; (3) People who are addicted to or dependent on opioids or hypnotics; (4) Patients with preoperative behavioral disorder or mental illness who have used psychotropic drugs; (5) History of chronic pain; (6) Those who have contraindications to the use of narcotic drugs, dexmedetomidine, estaketamine and non-steroidal anti-inflammatory drugs in this experiment.

Design outcomes

Primary

MeasureTime frame
Hospital Anxiety and Depression Scale score;Brain-derived neurotrophic factor;Interleukin-6;Interleukin-10;

Secondary

MeasureTime frame
Blood pressure;Heart rate;Pain scores;Generalized anxiety disorder scale score;

Countries

China

Contacts

Public ContactJing Deng

Affiliated Hospital of Chengdu University

cddxfsyydj@126.com+86 135 4012 9213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026